A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors - Knudsen, Steen; Hansen, Anker; Foegh, Marie; Petersen, Steen; Mekonnen, Hana; Jia, Lin; Shah, Preeti; Martin, Victoria; Frykman, Gregory; Pili, Roberto (PloS one, 2023)
Keywords: 1-Phosphatidylinositol 3-kinase; AKT protein; Algorithms; Biological markers; Biology and Life Sciences; Biomarkers; Biopsy; Breast cancer; c-Kit protein; Cancer; Cancer therapies; Carcinoma, Renal cell; Care and treatment; Chemotherapy; Clinical outcomes; Clinical trials; Disease; Drug therapy; Endometrial cancer; Ethics; Fibroblast growth factor receptor 1; Health aspects; Informed consent; Inhibitor drugs; Kidney cancer; Kinases; Liver cancer; Medicine and Health Sciences; Messenger RNA; Metastasis; mRNA; Oncology, Experimental; Patients; Platelet-derived growth factor; Prognosis; Protein-tyrosine kinase receptors; Renal cell carcinoma; Solid tumors; Statistical analysis; Survival; Targeted cancer therapy; TOR protein; Tumors; Tyrosine; Vascular endothelial growth factor; United States